7-30612215-T-C
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PM1PM2PM5PP3_StrongPP5_Very_Strong
The NM_002047.4(GARS1):c.1001T>C(p.Ile334Thr) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 12/21 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. I334M) has been classified as Likely pathogenic.
Frequency
Consequence
NM_002047.4 missense
Scores
Clinical Significance
Conservation
Publications
- Charcot-Marie-Tooth disease type 2DInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), Orphanet
- neuronopathy, distal hereditary motor, type 5AInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Illumina, Laboratory for Molecular Medicine
- spinal muscular atrophy, infantile, James typeInheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| GARS1 | ENST00000389266.8 | c.1001T>C | p.Ile334Thr | missense_variant | Exon 8 of 17 | 1 | NM_002047.4 | ENSP00000373918.3 | ||
| GARS1 | ENST00000675651.1 | c.1001T>C | p.Ile334Thr | missense_variant | Exon 8 of 17 | ENSP00000502513.1 | ||||
| GARS1 | ENST00000675810.1 | c.899T>C | p.Ile300Thr | missense_variant | Exon 7 of 16 | ENSP00000502743.1 | ||||
| GARS1 | ENST00000675693.1 | c.833T>C | p.Ile278Thr | missense_variant | Exon 9 of 18 | ENSP00000502174.1 | ||||
| GARS1 | ENST00000675051.1 | c.800T>C | p.Ile267Thr | missense_variant | Exon 8 of 17 | ENSP00000502296.1 | ||||
| GARS1 | ENST00000674815.1 | c.632T>C | p.Ile211Thr | missense_variant | Exon 8 of 17 | ENSP00000502799.1 | ||||
| GARS1 | ENST00000674851.1 | c.632T>C | p.Ile211Thr | missense_variant | Exon 9 of 18 | ENSP00000502451.1 | ||||
| GARS1 | ENST00000444666.6 | n.1001T>C | non_coding_transcript_exon_variant | Exon 8 of 18 | 3 | ENSP00000415447.2 | ||||
| GARS1 | ENST00000674616.1 | n.*715T>C | non_coding_transcript_exon_variant | Exon 9 of 18 | ENSP00000502408.1 | |||||
| GARS1 | ENST00000674643.1 | n.1001T>C | non_coding_transcript_exon_variant | Exon 8 of 17 | ENSP00000501636.1 | |||||
| GARS1 | ENST00000674737.1 | n.*339T>C | non_coding_transcript_exon_variant | Exon 9 of 18 | ENSP00000502464.1 | |||||
| GARS1 | ENST00000674807.1 | n.1001T>C | non_coding_transcript_exon_variant | Exon 8 of 16 | ENSP00000502814.1 | |||||
| GARS1 | ENST00000675529.1 | n.*871T>C | non_coding_transcript_exon_variant | Exon 9 of 18 | ENSP00000501655.1 | |||||
| GARS1 | ENST00000675859.1 | n.1001T>C | non_coding_transcript_exon_variant | Exon 8 of 15 | ENSP00000502033.1 | |||||
| GARS1 | ENST00000676088.1 | n.*943T>C | non_coding_transcript_exon_variant | Exon 10 of 19 | ENSP00000501884.1 | |||||
| GARS1 | ENST00000676140.1 | n.1001T>C | non_coding_transcript_exon_variant | Exon 8 of 17 | ENSP00000502571.1 | |||||
| GARS1 | ENST00000676164.1 | n.*452T>C | non_coding_transcript_exon_variant | Exon 8 of 17 | ENSP00000501986.1 | |||||
| GARS1 | ENST00000676210.1 | n.*290T>C | non_coding_transcript_exon_variant | Exon 9 of 18 | ENSP00000502373.1 | |||||
| GARS1 | ENST00000676259.1 | n.*433T>C | non_coding_transcript_exon_variant | Exon 8 of 17 | ENSP00000501980.1 | |||||
| GARS1 | ENST00000676403.1 | n.1001T>C | non_coding_transcript_exon_variant | Exon 8 of 16 | ENSP00000502681.1 | |||||
| GARS1 | ENST00000674616.1 | n.*715T>C | 3_prime_UTR_variant | Exon 9 of 18 | ENSP00000502408.1 | |||||
| GARS1 | ENST00000674737.1 | n.*339T>C | 3_prime_UTR_variant | Exon 9 of 18 | ENSP00000502464.1 | |||||
| GARS1 | ENST00000675529.1 | n.*871T>C | 3_prime_UTR_variant | Exon 9 of 18 | ENSP00000501655.1 | |||||
| GARS1 | ENST00000676088.1 | n.*943T>C | 3_prime_UTR_variant | Exon 10 of 19 | ENSP00000501884.1 | |||||
| GARS1 | ENST00000676164.1 | n.*452T>C | 3_prime_UTR_variant | Exon 8 of 17 | ENSP00000501986.1 | |||||
| GARS1 | ENST00000676210.1 | n.*290T>C | 3_prime_UTR_variant | Exon 9 of 18 | ENSP00000502373.1 | |||||
| GARS1 | ENST00000676259.1 | n.*433T>C | 3_prime_UTR_variant | Exon 8 of 17 | ENSP00000501980.1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Charcot-Marie-Tooth disease type 2 Pathogenic:1
This sequence change replaces isoleucine, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 334 of the GARS protein (p.Ile334Thr). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individuals with clinical features of autosomal dominant Charcot-Marie-Tooth disease (internal data). ClinVar contains an entry for this variant (Variation ID: 958512). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt GARS protein function with a positive predictive value of 95%. This variant disrupts the p.Ile334 amino acid residue in GARS. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 17101916, 24604904, 25168514, 25476837). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic.
not provided Pathogenic:1
PP3, PM1, PM2, PM5
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at